Return to homepagePandemic Pact

CoVaMax: Study of the levers to maximize vaccination against Covid-19 in the adult population aged 18 to 64 at low risk of severe infection.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    ANR

  • Principal Investigator

    Unspecified Michaël Schwarzinger

  • Research Location

    France

  • Lead Research Institution

    Bordeaux Population Health Research Center (BPH) - Université de Bordeaux

  • Research Priority Alignment

    N/A

  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Vaccine/Therapeutic/ treatment hesitancy

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older), Older adults (65 and older)

  • Vulnerable Population

    Vulnerable populations unspecified

  • Occupations of Interest

    Unspecified

Abstract

The CoVaMax project, coordinated by Michaël Schwarzinger (UMR 1219 - Bordeaux Population Health Research Center (BPH) - University of Bordeaux), aims to define a behavioral model of pandemic vaccination in the adult population aged 18 to 64, and to evaluate the most promising levers for maximizing vaccination against SARS-CoV-2, overall and according to certain major vaccination targets: health professionals, the population alternately defined by the level of risk of severe Covid-19 (the most elderly) or SARS-CoV-2 transmission (youngest adults), and the most socially disadvantaged populations.